Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Comprehensive Psychiatry|September 25, 2003
Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertralineKathleen T Brady, Cathryn M Clary
Journal of Psychiatric Research|September 24, 2004
Improvement of anger at one week predicts the effects of sertraline and placebo in PTSDJonathan Davidson, Lawrence R Landerman, Cathryn M Clary
The Journal of Clinical Psychiatry|February 13, 2002
Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatmentMark H Rapaport, Jean Endicott, Cathryn M Clary
Primary Care Companion to the Journal of Clinical Psychiatry|March 12, 2004
From the Bench to the Trench: A Comparison of Sertraline Treatment of Major Depression in Clinical and Research Patient SamplesR Bruce Lydiard, Philip Perera, Evan Batzar, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 16, 2005
Symptoms of late-life depression: frequency and change during treatmentJ Craig Nelson, Cathryn M Clary, Andrew C Leon, et al.
The Journal of Clinical Psychiatry|June 27, 2007
Acute worsening of chronic depression during a double-blind, randomized clinical trial of antidepressant efficacy: differences by sex and menopausal statusAnne T Harvey, Beryl S Silkey, Susan G Kornstein, et al.
Depression and Anxiety|October 11, 2005
Multidimensional effects of sertraline in social anxiety disorderKathryn M Connor, Jonathan R T Davidson, Henry Chung, et al.
Molecular Metabolism|February 5, 2023
VLDL receptor gene therapy for reducing atherogenic lipoproteinsRonald M Krauss, Jonathan T Lu, Joseph J Higgins, et al.
Psychopharmacology|September 5, 2003
The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorderL Kathryn Durham, Suzin M Webb, Patrice M Milos, et al.
The Journal of Clinical Psychiatry|April 21, 2004
Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparisonBorwin Bandelow, Kirsten Behnke, Sergio Lenoir, et al.
Pageof 4